Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Author Archives: Warren Woessner
PTO Proposes to Change Claim Construction Standard Used by PTAB
On May 9th, the USPTO released a short “Notice of proposed rulemaking” entitled “Changes to the Claim Construction Standard for Interpreting Claims in Trial Proceedings Before the Patent Trial and Appeal Board.” In brief the Notice proposes to replace the broadest … Continue reading
Posted in Claim Interpretation, PTAB, USPTO Practice and Policy
Tagged BRI, broadest reasonable interpretation, Phillips, PTAB
1 Comment
Ex Parte Buck: Can a Composition Claim be a Natural Phenomenon?
In a recent decision, Ex Parte Buck, Appeal no. 2017-005470 (PTAB, April 20, 2018), the Board affirmed the examiner’s ruling that a composition claim reciting two natural products was patent-ineligible as an attempt to claim a natural phenomenon: 7. A … Continue reading
Posted in Patent Eligible Subject Matter
Tagged Bhaget, Buck, natural phenomenon, natural product, PTAB
1 Comment
Upcoming Webinar: Top 5 Court Decisions Impacting Future IP Litigation
Within the last few years, the Federal Circuit and Supreme Court have handed down decisions that altered the landscape of both patent prosecution and enforcement, ranging from venue and attorneys’ fees to the standards for obviousness and patent eligibility. Please … Continue reading
Posted in Webinar
Tagged Enforcement, Federal Court, Litigation, Obviousness, Patent Prosecution, Supreme Court, Webinar
1 Comment
Fed. Cir. Affirms Unclean Hands Defense in Gilead v. Merck
On April 25th, a Fed. Cir. panel of Judges Taranto, Clevenger and Chen affirmed the unenforceability of two Merck patents covering a drug presently marketed as Sovaldi(r) to treat hepatitis C, sofosbuvir. Gilead Sciences, Inc. v. Merck & Co., Appeal … Continue reading